MP Biomedicals

Santa Ana, United States Founded: 1959 • Age: 67 yrs Acquired By Valiant
Reagents for diagnostics, chemical and life science research

About MP Biomedicals

MP Biomedicals is a Healthcare company based in Santa Ana (United States) founded in 1959 by Milan Panic, and was acquired by Valiant in October 2015. Reagents for diagnostics, chemical and life science research. MP Biomedicals has completed 1 acquisition, including Qbiogene. Its chief executive, as recorded, is Kimberly Keniston. Its website mpbio.com draws about 112 thousand monthly visits. Its Indian entity Mp Biomedicals India Private Limited reported revenue of β‚Ή46.69 Cr. Its focus areas include Diversified Diagnostics.

Company details

MP Biomedicals was established in 1959 in Santa Ana, United States, by Milan Panic, a Serbian businessman and former Prime Minister of Yugoslavia. Reagents for diagnostics, chemical analysis, and life science research are provided through a product line exceeding 55,000 items, including assays, chemicals, labware, and instruments. Operations are centered on supporting laboratory and research applications in the biotechnology sector.

Operational Areas
Key Metrics
  • Indian entity revenue
    ₹46.69 Cr

    FY 2024 · +37% YoY

  • Indian entity net loss
    -₹24 Lakh

    FY 2024 · -1% margin

  • Indian entity EBITDA
    ₹62.5 Lakh

    FY 2024 · 1% margin

  • Investors
  • Investments & Acquisitions
  • Acquired by
    Valiant

    (Oct 2015)

Investors in MP Biomedicals

MP Biomedicals has secured backing from 1 investor. Prominent investors backing the company include Valiant CN.

All
InvestorDescriptionFounded YearDomainLocation
Pharmaceutical intermediates and optical chemical products are manufactured.
1995valiant-cn.comYantai, China
Premium access

Investor details for MP Biomedicals

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Mp Biomedicals India Private Limited (MP Biomedicals)

Mp Biomedicals India Private Limited is the primary company behind MP Biomedicals. The board of Mp Biomedicals India Private Limited currently have 2 directors; the longest-serving is Du Yang, appointed in 2019. 10 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Du Yang
DIN 08534767
Director12 Aug 20197 yrs 3 moMp Biomedicals India Private Limited
Rahul Tewari
DIN 08238673
Director19 Jul 20242 yrs 3 moMp Biomedicals India Private Limited

People of MP Biomedicals

2 people are tracked at MP Biomedicals (2 in leadership).

NameRoleGroup
Milan Panic
FounderLeadership
Kimberly Keniston
CEOLeadership
Premium access

Complete people profiles for MP Biomedicals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of MP Biomedicals

Figures of Mp Biomedicals India Private Limited, the primary company behind MP Biomedicals, for FY 2024. Revenue was ₹46.69 Cr (+37% year on year). Net loss was -₹24 Lakh (-1% margin). EBITDA was ₹62.5 Lakh (1% margin). Revenue has grown at a compounded annual rate of +12% over three years and +20% over five years.

  • ₹46.69 CrRevenue · FY 2024 · +37% YoY
  • -₹24 LakhNet loss · -1% margin
  • ₹62.5 LakhEBITDA · 1% margin
  • ₹12 LakhPaid-up capital
  • +12%Revenue CAGR, 3 years
  • +20%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Mp Biomedicals India Private Limited are on its company page.

Premium access

Detailed financial statements for MP Biomedicals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by MP Biomedicals

MP Biomedicals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Qbiogene.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Molecular biology products are supplied by Qbiogene.
qbiogene.com0Jul 2004β€’β€’β€’β€’
Premium access

Complete acquisition details for MP Biomedicals

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of MP Biomedicals

3 dated milestones of MP Biomedicals across 56 years, from founding to its latest funding, stage changes and deals.

  1. Founded MP Biomedicals is founded.
  2. Acquisition Acquires Qbiogene.
  3. Exit Acquired by Valiant.

Web traffic of MP Biomedicals

The website of MP Biomedicals (mpbio.com) receives about 112.2K visits a month.

  • Monthly visits
    112.2K

    ▲ 17% vs previous month

Similar websites

Websites whose visitors overlap most with MP Biomedicals. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
caymanchem.com
100%
393.1K#148,469View details
invitrogen.com
88%
5.2K#3,688,642View details
rpicorp.com
rpicorp.com
87%
#1,292,794–
peprotech.com
84%
View details
bioline.com
84%
42.9K#824,098View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for MP Biomedicals

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Diagnostics & Lab Tech

3 companies that operate in the same segment as MP Biomedicals (Diagnostics & Lab Tech) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
At-home health tests for biomarkers, nutrition, and hormone analysis.
2014Austin, Texas, United StatesUSD 330 M336
Blood testing services are offered using finger-prick microsamples.
2017Austin, Texas, United StatesUSD 37.7 M
Manufactures clinical diagnostic test kits
1971Irvine, California, United StatesUSD 4.45 M54
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Mp Biomedicals

Premium access

Complete news archive for MP Biomedicals

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MP Biomedicals

MP Biomedicals was founded in 1959.

MP Biomedicals is headquartered in Santa Ana, United States. It is registered at Santa Ana, California, United States.

Kimberly Keniston is the CEO of MP Biomedicals, as recorded in our data.

The primary company behind MP Biomedicals, Mp Biomedicals India Private Limited, reported revenue of β‚Ή46.69 Cr for FY 2024, up 37% year on year.

MP Biomedicals was established in 1959 in Santa Ana, United States, by Milan Panic, a Serbian businessman and former Prime Minister of Yugoslavia. Reagents for diagnostics, chemical analysis, and life science research are provided through a product line exceeding 55,000 items, including assays, chemicals, labware, and instruments. Operations are centered on supporting laboratory and research applications in the biotechnology sector.

MP Biomedicals has made 1 acquisition, including Qbiogene.

MP Biomedicals has 1 investor. Key investors include Valiant CN.

MP Biomedicals operates through Mp Biomedicals India Private Limited.

Yes. MP Biomedicals was acquired by Valiant in October 2015.

The legal entities of MP Biomedicals currently have 2 directors, including Du Yang, Rahul Tewari.

The website of MP Biomedicals receives about 112 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available